Eschler Asset Management »

Viking Therapeutics shares owned by Eschler Asset Management

Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by Eschler Asset Management from 13F filings

Historical chart of Eschler Asset Management investment in Viking Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viking Therapeutics held by Eschler Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viking Therapeutics by Eschler Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.0M 12k 82.00

More positions owned by Eschler Asset Management

Microstrategy Cl A New (MSTR)
Vaneck Etf Trust Junior Gold Mine (GDXJ)
Vaneck Etf Trust Gold Miners Etf (GDX)
Freeport-mcmoran CL B (FCX)
Agnico (AEM)
Rio Tinto Sponsored Adr (RIO)
Noah Hldgs Spon Ads (NOAH)
Pdd Holdings Sponsored Ads (PDD)
Abrdn Healthcare Investors Sh Ben Int (HQH)
Newmont Mining Corporation (NEM)
Alphabet Cap Stk Cl A (GOOGL)
Brookfield Real Assets Incom Shs Ben Int (RA)
I-80 Gold Corp (IAUX)
Meta Platforms Cl A (META)
Immunocore Hldgs Ads (IMCR)

View all positions for Eschler Asset Management

Top funds holding Viking Therapeutics

Vanguard Group
BlackRock
BlackRock
State Street Corporation
Susquehanna International
Citadel Advisors
Jpmorgan Chase & Co
Geode Capital Management
Perceptive Advisors
Pictet Asset Management Holding SA
Perpetual
Alliancebernstein
Goldman Sachs Group
Braidwell
Jane Street

View all funds holding Viking Therapeutics